Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease

被引:30
作者
Giordani, L. [1 ]
Quaranta, M. G. [1 ]
Marchesi, A. [3 ]
Straface, E. [1 ]
Pietraforte, D. [2 ]
Villani, A. [3 ]
Malorni, W. [1 ,4 ]
Del Principe, D. [1 ,4 ]
Viora, M. [1 ]
机构
[1] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy
[2] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy
[3] Bambino Gesu Pediat Hosp, Dept Pediat, Rome, Italy
[4] Ist San Raffaele Sulmona, Laquila, Italy
关键词
B lymphocytes; humoral immune response; Ig; Kawasaki disease; TLR-9; LYMPH-NODE SYNDROME; BLOOD MONONUCLEAR-CELLS; CORONARY-ARTERY; LYMPHOCYTES; ACTIVATION; SUBSETS; ABNORMALITIES; EXPRESSION;
D O I
10.1111/j.1365-2249.2010.04297.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Kawasaki disease (KD) is an acute vasculitis affecting mainly infants and children. Human B cells express Toll-like receptor (TLR)-9, whose natural ligands are unmethylated cytosine-guanine dinucleotide (CpG) motifs characteristic of bacterial DNA. The aim of this study was to clarify the pathogenesis of KD analysing the activation status of peripheral blood mononuclear cells (PBMC), focusing on B lymphocyte activation and functions. Ten patients and 10 age-matched healthy donors were recruited from the Bambino Gesu Hospital of Rome, Italy and enrolled into this study. We determined phenotype profile and immunoglobulin (Ig) production of PBMC from KD patients and age-matched controls. We found that the frequency of CD19(+) B lymphocytes and CD19(+)/CD86(+) activated B lymphocytes from KD patients during the acute phase before therapy was increased significantly. Moreover, B lymphocytes of acute-phase KD patients were more prone to CpG oligodeoxynucleotide (ODN) activation compared with the age-matched controls, as assessed by a significant increase of the number of IgA-secreting cells (SC). In the same patients we found a marked increase of IgM, IgG, interleukin (IL)-6 and tumour necrosis factor (TNF)-alpha production compared with the control group. In addition, in two convalescent KD patients, conventional treatment with intravenous immunoglobulin (IVIG) restored the normal frequency of CD19(+) B cells, the number of IgA-, IgM- and IgG-SC and the production of IL-6 and TNF-alpha. Our findings indicate that the percentages of peripheral B lymphocytes of acute-phase KD patients are increased and are prone to bacterial activation in terms of increased numbers of IgA-SC and increased production of IL-6 and TNF-alpha inflammatory cytokines. Thus, our data support the hypothesis of an infectious triggering in KD.
引用
收藏
页码:346 / 353
页数:8
相关论文
共 34 条
[1]   T cell activation profiles in Kawasaki syndrome [J].
Brogan, P. A. ;
Shah, V. ;
Clarke, L. A. ;
Dillon, M. J. ;
Klein, N. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 151 (02) :267-274
[2]   Kawasaki syndrome [J].
Burns, JC ;
Glodé, MP .
LANCET, 2004, 364 (9433) :533-544
[3]   Early activation does not translate into effector differentiation of peripheral CD8T cells during the acute phase of Kawasaki disease [J].
Ehara, Hiroshi ;
Kiyohara, Koji ;
Izumisawa, Yasuhiro ;
Ito, Taichi .
CELLULAR IMMUNOLOGY, 2010, 265 (01) :57-64
[4]   MONONUCLEAR CELL SUBSETS AND CORONARY-ARTERY LESIONS IN KAWASAKI-DISEASE [J].
FURUKAWA, S ;
MATSUBARA, T ;
YABUTA, K .
ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (06) :706-708
[5]   COMPARISON OF KAWASAKI-DISEASE AND INFECTIOUS-MONONUCLEOSIS IN TERMS OF NATURAL-KILLER-CELL AND CD8+ T-CELL SUBSETS [J].
FURUKAWA, S ;
MATSUBARA, T ;
TSUJI, K ;
MOTOHASHI, T ;
WATANABE, T ;
UMEZAWA, Y ;
YABUTA, K .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) :416-417
[6]   The role of anti-endothelial cell antibodies in Kawasaki disease -: in vitro and in vivo studies [J].
Grunebaum, E ;
Blank, M ;
Cohen, S ;
Afek, A ;
Kopolovic, J ;
Meroni, PL ;
Youinou, P ;
Shoenfeld, Y .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 130 (02) :233-240
[7]   Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides [J].
Hornung, V ;
Rothenfusser, S ;
Britsch, S ;
Krug, A ;
Jahrsdörfer, B ;
Giese, T ;
Endres, S ;
Hartmann, G .
JOURNAL OF IMMUNOLOGY, 2002, 168 (09) :4531-4537
[8]   Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease [J].
Ikeda, K. ;
Yamaguchi, K. ;
Tanaka, T. ;
Mizuno, Y. ;
Hijikata, A. ;
Ohara, O. ;
Takada, H. ;
Kusuhara, K. ;
Hara, T. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 160 (02) :246-255
[9]   Immunoregulatory changes in Kawasaki disease [J].
Jason, J ;
Gregg, L ;
Han, A ;
Hu, A ;
Inge, KL ;
Eick, A ;
Tham, I ;
Campbell, R .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 84 (03) :296-306
[10]  
KAWASAKI T, 1974, PEDIATRICS, V54, P271